R1 RCM Inc. (NASDAQ:RCM – Get Rating) has been assigned an average rating of “Moderate Buy” from the fourteen brokerages that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $16.85.
Several research analysts have commented on RCM shares. TheStreet downgraded R1 RCM from a “c-” rating to a “d+” rating in a research note on Monday, November 21st. Guggenheim raised R1 RCM from a “neutral” rating to a “buy” rating and set a $15.00 price target for the company in a research report on Wednesday, December 7th. Cowen lowered their price target on R1 RCM from $34.00 to $25.00 in a research report on Monday, November 14th. SVB Leerink decreased their target price on R1 RCM from $35.00 to $16.00 and set an “outperform” rating for the company in a research report on Wednesday, November 9th. Finally, KeyCorp increased their price target on R1 RCM from $15.00 to $20.00 and gave the stock an “overweight” rating in a research note on Thursday, February 2nd.
Insider Activity at R1 RCM
In other news, CEO Lee Rivas acquired 71,767 shares of the stock in a transaction that occurred on Tuesday, February 21st. The shares were bought at an average cost of $13.93 per share, for a total transaction of $999,714.31. Following the acquisition, the chief executive officer now owns 71,767 shares in the company, valued at approximately $999,714.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 63.50% of the stock is owned by company insiders.
Institutional Trading of R1 RCM
R1 RCM Stock Performance
RCM opened at $14.09 on Tuesday. The firm’s 50-day simple moving average is $13.27 and its 200-day simple moving average is $14.74. R1 RCM has a twelve month low of $6.71 and a twelve month high of $27.86. The firm has a market cap of $5.87 billion, a price-to-earnings ratio of -100.64, a PEG ratio of 7.60 and a beta of 0.82.
R1 RCM (NASDAQ:RCM – Get Rating) last announced its quarterly earnings results on Thursday, February 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.06). R1 RCM had a negative net margin of 3.19% and a positive return on equity of 0.05%. The firm had revenue of $532.80 million during the quarter, compared to analyst estimates of $519.28 million. During the same quarter in the prior year, the business earned $0.11 earnings per share. The business’s revenue was up 33.6% on a year-over-year basis. As a group, sell-side analysts anticipate that R1 RCM will post 0.2 EPS for the current fiscal year.
R1 RCM Company Profile
R1 RCM, Inc engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.
- Get a free copy of the StockNews.com research report on R1 RCM (RCM)
- Go Where the Money Is. Here’s 3 Top Bank Dividend Stocks to Buy
- Another Catalyst For Mullen Automotive Stock
- Solar Tech-Services; Nextracker Should Be On Your Radar
- Is American Lithium a Safe Bet as Demand for Lithium Soars
- Highwoods Properties, High-quality Real Estate for a Discount
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.